Innovation in tackling the challenge

There is a clear need for a major effort to integrate molecular, behavioral, nutritional, clinical, social and environmental epidemiology dataencompassing exposure data from occupational studies, supplying novel genetic, epigenetic, phenotypic and imaging data in a major European ME/CFS study, with the clear purpose of better understanding ME/CFS, and to open the possibility of Europe-wide translational research on ME/CFS, integrating synergistically the national efforts with a major H2020 initiative.

The primary contribution to innovation will be the coordination of an effort on the employment of new technologies, big data, digitalisation in patient management, new basic science contributions such as protein-protein and protein-carbohydrate interaction studies, and novel visualisation methods.